China has sold nearly four billion masks to foreign countries since March, officials said on Sunday, as they tried to stem widespread fears over the quality of medical exports. Despite Chinese cases dwindling, Beijing has encouraged factories to increase production of medical supplies as parts of the world face a protective equipment shortage.
China has exported 3.86 billion masks, 37.5 million pieces of protective clothing, 16,000 ventilators and 2.84 million COVID-19 testing kits since March 1, customs official Jin Hai said, with orders to more than 50 countries. She added the country’s medical supply exports were valued at 10.2 billion yuan ($1.4 billion). However numerous nations — including the Netherlands, the Philippines, Croatia, Turkey and Spain — have complained about substandard or faulty medical products shipped from China.
Also read |U.S. braces itself for ‘toughest virus week’
Recall of orders
Last week, the Dutch government recalled 6,00,000 masks out of a Chinese shipment of 1.3 million that did not meet quality standards. China said the manufacturer “stated clearly that (the masks) are non-surgical.” Spain also rejected thousands of rapid test kits sent by an unauthorised Chinese company after it found that they were unreliable last week. Chinese officials hit back on Sunday at media reports over defective medical supplies, saying that they “did not reflect the full facts”. “In reality there are various factors, such as China having different standards and different usage habits to other countries. Even improper use can lead to doubts over quality,” said Jiang Fan, an official with the Ministry of Commerce.
The comments echoed remarks from Foreign Ministry spokeswoman Hua Chunying, who over the past week has repeatedly urged Western media not to “politicise” or “hype up” the issue.
Tighter regulations
Earlier this week, Beijing tightened regulations for exported virus medical equipment, requiring products to fulfil both domestic licensing standards and that of their destination countries.
China has also increased its production capacity of COVID-19 testing kits to over 4 million a day, said Zhang Qi, an official with the National Medical Products Administration.
